Brachytherapy device developer Xoft of Sunnyvale, CA, has appointed a new chief medical officer (CMO), the company reported.
Dr. Mark Carol will focus on the continued development of breast and endometrial applications of the company's Axxent electronic brachytherapy system, as well as exploration of other indications and markets, according to Xoft.
Carol previously served as a consulting medical director for Xoft. He has founded several medical device companies, including Nomos, a stereotactic and holographic-guided surgery technique developer; DxTx, which develops new approaches to the diagnosis and treatment of early-stage lung cancer; and Enki, which focuses on developing radiation therapy systems for benign and malignant disease.
Related Reading
FDA clears Xoft's new applicators, May 21, 2008
Xoft medical director wins Gotham's Ira Sohn prize, April 4, 2008
FDA clears Xoft brachytherapy device, March 17, 2008
Xoft reports new CPT code, July 26, 2007
Xoft reaches milestone, April 25, 2007
Copyright © 2008 AuntMinnie.com
